Vanguard Group Inc Concert Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.34 - $5.84 $300,388 - $404,209	69,214 Added 3.76%	1,910,984 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $1.08 Million - $1.82 Million	252,572 Added 15.89%	1,841,770 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $1.99 Million - $4.52 Million	711,037 Added 80.97%	1,589,198 $6.69 Million
Q1 2022 May 13, 2022	SELL	$2.73 - $3.94 $918,522 - $1.33 Million	-336,455 Reduced 27.7%	878,161 $2.96 Million
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $62,795 - $98,511	-23,344 Reduced 1.89%	1,214,616 $3.83 Million

Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $177 - $232	-56 Reduced -0.0%	1,237,960 $4.05 Million
Q2 2021 Aug 13, 2021	BUY	$3.77 - $5.24 $4.67 Million - $6.49 Million	1,238,016 New	1,238,016 $5.22 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.